Rhofade scores a mention in The New York Times

Allergan will be pleased to discover that they scored a free (one presumes) mention of their Rhofade product in the New York Times Fashion & Style section today. Given that Rhofade is a prescription item, this amounts to publicity of the sort that they cannot buy.

How to Go Makeup-Free This Summer


Summer’s heat and humidity make a face full of makeup feel oppressive. But how to go without? First, address the dark spots, redness and scars we conceal with foundation. All can be improved in the hands of a good doctor.

Erase Redness

Visible blood vessels, commonly called spider veins, occur with aging and sun exposure. The weblike redness we see is caused by a dilation of the blood vessel. “Intense pulsed light treatments use light at a frequency that is absorbed by the lining of the vessels, which destroys the cells and collapses the vessel,” said Norman Rowe, a plastic surgeon in New York.

There is also a new prescription cream called Rhofade that constricts blood vessels near the surface of the skin to reduce rosacea-related redness for about 12 hours.

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

2 Reader Comments

  1. irene simmonett says:

    That’s great but when can we get Rhofade in UK?

    • Gerald Kelly says:

      Irene I’m from Ireland, it doesn’t seem like Galderma have submitted it for approval in Europe yet. They are probably still in talks with the European commission .. No doubt they will eventually get it approved in Europe as the European market for rosacea is huge.. Its estimated that ATLEAST 1/10 people in the UK have rosacea, with some reports rising to 3 out of 10 people have it.

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.